Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03510208
Title Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eben Rosenthal
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.